earlier is important with the stock here levitating. never in the history of the stock market has a stock gained $60 oh billion in market cap i would not be a biter >> brian in the the sea haks miss goldman downgrade a week ago. >> thank you, we'll see you tomorrow my mission is simple -- to make you money i'm here to level the playing field for all investors. there's always a bull market somewhere. and i promise to help you find it "mad money" starts now hey, i'm cramer. welcome to "mad money. welcome to cramerica other people want to make friends. i'm just trying to make you some money. my job isn't just to entertain but to educate and teach you so call me at 1-800-743-cnbc. or tweet me @jimcramer. the bears refuse to acknowledge that we have learned our lessons from the great recession.

yet a whole generation of people did realize, they did, that you shouldn't take on too much debt. that you should live within your means, you shouldn't recklessly flip houses or create financial instruments no one can understand it's a bad idea to take out loans you'll never be able to repay. it's an even worse idea for the banks to write those kinds of loans. look, people, it is just a fact. we got more frugal in this country. we got less reckless in this country. we got more prudent. the same way that my parents' generation learned not to trust banks for decades after the great depression listen to me, it did happen. interesting date day for the average, dow gained 31 points, s&p inched occupy .03, nasdaq up

1% everyone seems to recognize this change in human behavior, everybody except for the barrish a armageddonists, they refuse to believe people can learn from their mistakes that's why they think the whole recovery and stock market is a sham, some pumped up federal reserve drama, the slump, the comeback, and now where everything goes carfluey, and we're back to where we started ten years ago. it feels like something good to me happens every day in this economy, every single day, something good that is ignored or judged negatively for example, this morning we got a housing permit number that was the highest in 12 years, the moment the news broke, well, my twitter feed, it exploded with people predicting that this number is a sign that we're about to repeat the housing crisis it was an insanely negative

judgment just rational, very good data. i didn't see anyone point out that thank heavens the fed was able to reverse the beating it gave to the economy a year ago i don't know a soul who noted that it was good news because housing punches above its weight so the strength will benefit not just the home builders in the bags and the retailers, not to mention everyone involved in the housing related service economy, the brokers, the lawyers, the accountants, the people who do the title work it's all there this number was a huge force multiplier it's not a sign that we're headed for another recession for heaven's sake. it's a sign that we're finally, finally, recovered from the last one. when the great recession started, do you know that we had 301 million people living in this country now we have 329 billion, wouldn't you expect more home building, but the housing permit numbers are merely back to where they were when we had 30 #0

million people that's pathetic considering our population growth but people are prudent, people are staying at home people aren't taking down mortgages until they have enough money that they won't return to the couch of their parents don't try to overthink this economy, people. good news is actually good news, not a sign that things have gotten overheated and the end is nigh today caterpillar's management rang the bell, came down there, 90th anniversary, a decade ago, the old caterpillar was sync or swim, busy making ill advised equipment. the new cat would never do such a dumb deal. ceo runs a lean and balanced business, good balance sheet no longer hostage to china, and it consistently returns cash to its shareholders, via dividend boosts and buy backs, consistent, can't learn from the great recession. they're not going to leave to reach for the stores only to find that the fault is indeed in themselves

or consider it, let's go there, why don't we just really go there. let's just go there. let's go to netflix and tesla, the two most despised stocks by the bear, the ones that they hate, for months we have heard netflix's domestic sign ups have been weakening, how this company will be the big loser, with competitors launching streaming services today we learned netflix has 90 million subscribers outside the u.s. and canada. they have done a brilliant job creating retail content by people all over the world. maybe netflix is going to be fine maybe much better than you think. tesla, tesla, the electric car maker has been getting some accolades from formers bears lately because it's so far ahead of the competition on electri

electfication, tesla is an auto company and stocks have been roaring. not on elon musk brag tweets, and the potential of very big earnings not that far. al grass energy, a lousy pipeline company, maybe they have value, 10% deal valued at $6 million total dogs for ages, terrible, and running from ohio to wyoming to cushing, oklahoma, no danka, but hey, you know what, maybe there's hope for this disastrous group that so many rich people are in we have watched the stocks of macy's and bear after bear has pounded them into submission now they are rallying, why, maybe because the consumer is so strong, they are shopping at those joints, and they're returning, remember that kohl's thing where you can return it to kohl's and it goes back to

amazon people don't want to focus on that what they want to focus at is how bad fedex keeps being, that's what they want, bad news bears. just a second. bad news bears there you go well, you know, doesn't even care that we have a phase one trade deal, same goes for the bed, bath and beyond, i'm thinking of shopping there where the new ceo broomed many of the executives today stock goes up 11%. maybe bed bath has been given a safe after all you know what irritates the most, the banks, yeah, those dastardly banks. their stocks keep hitting new highs as bulls tiptoe into those stocks with above average dividends and cheap valuations and extended hangover from the great recession. the bears need senator elizabeth

warren to own more stock so she can blow it out, not that she would own any anyway it's not just there's good news, the bad news doesn't matter to this market. we found out boeing is going to stop production of the 737 max because they're not allowed to sell them until the planes are certified. good idea. over and over again we were told this would be horrible for boeing, and horrible for the u.s. economy how much was boeing's stock down today, 10%, 5%, i don't know, 15%, how about the fact that the stock was flat yep, instead of fretting about how we could be headed for another recession, we need to understand that we're really only just now crawling out of the national nightmare that was the great recession. even as things keep getting better, the bears refuse to believe it either they can't accept that people are more prudent than they were a decade ago or maybe they hate president trump so much they want a recession so that he won't be reelected

there are always partisans that don't want to believe the data, whether you love trump or you hate him and i bet you you do one or the other, there's no denying that the data is good, and it keeps getting better. bottom line, you got to stop looking at positive data and assuming it means that the economy is peeking and the world is coming to an end, like it's some sort of stephen king model. remember the one where the earth keeps getting chewed up and the only place left was like in maine. anyway, we know what a peak looks like we almost got one a year ago when the fed ratcheted up interest rates, rookie jay powell, nice guys, this is a healthy expansion, even if the armageddonists simply refuse to believe it you know what we should do, i think we should go to norman in california >> booyah, jim. >> as you know ppl provides power to areas of pennsylvania, kentucky and to almost 8 million customers in the uk, when the conservatives won the uk

election last week, ppl's share prices rose sharply, hit a 52-week high today in light of these developments, as well as issues related to coal, how do you see the future of the ppl share price. >> other than the fact i used to pay them fortunes. you know what, i like ppl, i mean, it yields 4.59, it's a good company i have been watching the semper by the way, that's a growth utility. i'm fine with ppl. people listen to me, maybe i am too impassioned, maybe i'm not impassioned enough this is a healthy expansion. please don't overthink the economy. don't let the haters tell you otherwise. stop going to my twitter feed from the nathan johnson school of business and telling me it's bad if it's good tonight, hey, remember, everyone gave up on it but with news that it expects higher than expected for 2020, is it time to circle

back to the stock, i'm talking to the ceo, are there any bargains left to be had, i've got some, i'm going off the charts, and why is stock that dropped 55% yesterday, can be a case study in investigating in speculative biostocks, that will make the bears so happy. don't make a move before you read this, and stay with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter have a question, tweet cramer, #madtweets send jim an email to madmoney@cnbc.com or give us a call at 1-800-743-cnbc miss something, head to madmoney.cnbc.com.

apple card. is a new kind of credit card, created by apple, so it's simple and transparent with a new level of privacy and security. it lives here and here- on your iphone, and it will save you 6% on holiday gifts at apple; like iphone, apple watch, airpods pro and so much more. ♪ apply in as little as a minute, right in the wallet app.

apply in as little - [narrator] at southern new hampshire university we're committed to making college more accessible by making it more affordable. that's why we're keeping our tuition the same for all online and campus programs through the year 2021. - [woman] i knew snhu was the place for me when i saw how affordable it was. i ran to my husband with my computer and i said, "look we can do this!" - [narrator] take advantage of some of the lowest online tuition rates in the nation. find your degree at snhu.edu.

when it comes to using data, which is why xfinity mobile is a different kind of wireless network that lets you design your own data. choose unlimited, shared data, or mix lines of each and switch any line, anytime. giving you more choice and control compared to other top wireless carriers. save up to $400 a year when you switch. plus, unwrap $250 off a new samsung phone. click, call or visit a store today. after spending most of the year in the dog house, big fa pharma has made a spectacular recovery, with eli lilly leading the way. lily, bottomed at 101 in late october, and since then it has surged back to $125, the stock

gaining 2% today alone, thanks to a bullish investor meeting. management gave excellent guidance for 2020 which is why i think it's got more room to run as the company is coming under fire for senator elizabeth warren over insulin pricing, got a chance to check in with dave rex, the chairman and ceo of ely roman. >> congratulations on an incredible update. what do you think is behind the excitement of lilly versus last time we talked. >> we were excited to roll out the guidance, which shows nice growth on the top line next thing. next year more than half our revenue will be products launched just in the last few years, and really no made patent on the horizon, trying to outgrow it lily has a unique position, several block buster drugs growing and really a relatively clean period ahead to grow the economy, reinvest in r and d,

create more great medicines. >> a diabetes, psoriasis update, oncology update, these could all be block bust sgleers. >> trulicity is treating diabetes around the world, controls, blood glue clo close. >> speaking of diabetic management, a company we are familiar with dex come, you announced the deal yesterday. >> they're a great partner they make the glucose monitoring equipment, what we do is connect that to the insulin delivery, a pen injector or eventually in a pump: by doing so we can better inform patients as to dose adjustments and keep track of how they did so they and their doctor can talk about improvements >>st it's information technology

coming to medicine it's one of the more exciting. >> and individualized medicine. >> super excited about o, it's targeting cancers, not where they are but why they grow, the jurn lying genetic mutation, 292 now just submitted to the fda, we announced that today, and we have another one. >> nonsmall cell lung. >> and thyroid. >> and so we hope to have that approved and launched next year. >> they take the thyroid out all the time, do you think there's a possibility they won't >> i think that will be the first line this is for metastatic thyroid, so when the cancer has spread to other parts of your body, this will directly attack, one of the primary drivers that that spreads in thyroid cancer. hope to launch it next year. there's another drug out of loxo acquisition, exciting data for blood cancers. >> right >> so those techniques to

conquer disease are really proving promising, we're excited about that also we announced the loxo management team is staying with lilly, going to help us grow a biotech inside lilly we're going to do that. >> i want people to know how important that is. in the conference call there were analysts saying why are you staying with lilly, but they are genuinely excited about what they're up to. >> they're super excited, entrepreneurs coming to the scale of fapharma we're a distributed company, we operate everywhere it's just great to have that talent stay. >> i have to talk about it because i'm the national spokesperson for the american migrating foundation, emgality, and ravo. >> thanks for doing that to represent patients. >> awareness is everything. >> more than 6 million would be

eligible for preventative medications like emgality, only half seek treatment. it's a devastating disease, one of the third most mono. >> there's 30 people and most doctors spend four hours in med school on migraines. >> another crazy statistic, 150 million work days lost each year in the united states it's a huge productivity hit on the economy. it comes along with our competitors, prevent migraines, cut in half the number of migraines for people with serious conditions: ravo, which will approve and launch in january, it's an abortive therapy, you take when you're having the migraine. they can be a one-two bunch, doctors can help patients suffering. we're broadening our reach to care >> do we have to worry about the eight hour, no operate machine, no drive that the fda may put on ravo. >> it's an important precaution. the way it works is different

from the trip tans, which have over side effects, it affects your heart, et cetera, so it's a different side effect, it's working in your brain, and because of that it's a little bit sedating, if it's in the evening, shouldn't be a problem, go to bed should get relief. >> that's i'm hoping for is the nighttime thing rj you're having a big day, it's a great day, and i'm thrilled for you, and all the shareholders, at the same time, senator warren, and senator bloomumenth inaccessible insulin, they say the finindings reveal that despt the promise of the lesser version of the brand name drug, the vast majority of pharmacies do not offer access to the drugs, is this a problem that lilly should have been addressing and what are you going to say about it? >> that's nonsense. >> nonsense? >> there's only a hundred of them >> i haven't read the details of the report

i read their press release i can tell you what the facts are today. many policy makers encourages us to lower the price of insulin. we did that. we launched a half price of our best selling product to say, okay, yes, there are some situations where patients have a deductible plan, they're exposed to more of the list price when they're paying or january right around the corner, people's deductibles reset. we could argue whether hatch price is enough. it's a pretty big difference we made that available this spring it's distributed widely, and i would say on the available pharmacies, one of the three national wholesalers have chosen not to cover it, some choose not to carry it. it's what that report should talk about is that the middlemen, both in the supply chain as well as pbm's insurance company, prefer high list products with a lot of rebate. this has a lower list price and less rebate. hat off to insurance companies like united health care and their arp plan, and anthem,

which are covering it, but only one out of four americans with part d coverage and in commercial coverage next year will have access to this this doesn't show we didn't try. we did try you can order this from your pharmacy this shows what's broken in the rest of the pharmaceutical notice. >> here's what i want to end on, will you please tell people how much, you can pick the migraine, the diabetes, i don't care, how much it costs to bring a darn new drug to market that can really help save lives. >> it is an expensive endeavor, $2 million for every medicine, and highly risky >> you put in these documents, he has drugs that fail you say this drug failed, this drug failed. >> yeah, it's part of the business most ideas we have don't work. that's what innovation is. but we put the money to work we put it at risk, and hopefully we have good scientists that do have good ideas and do make it

to market like emgality, not just financially but patients succeeding with our medicines. >> i want to congratulation you where you have great dividends, under your administration. >> thank you so much, jim. >> that's dave ritz, chairman and ceo of eli lilly, one of america's greatest companies "mad money" is back after the break. do you have concerns about mild memory loss related to aging? prevagen is the number one pharmacist-recommended memory support brand.

you can find it in the vitamin aisle in stores everywhere. prevagen. healthier brain. better life.

with the average assertion to new all time highs, how do we search for any bargains, are there some left? sure but you got to know where to look for them. tonight we're going off the charts with the help of carol, she is that brilliant technician and runs the queen.com web site, and also one of any colleagues at realmoney.com where i blog, to identify high quality stocks that could still have some room to run, and broaden looks for

names that have yet to meet higher time frame targets and circles back what exactly the heck does that mean there's one pattern that broaden noticed that seemed to play out time and again her whole method involves measuring past swings in a security, and running them through the prism of numbers, a series of ratios discovered by a math mathematician that repeat over and over again in the stock market, and it has been proven by her time and again in the years that we have used her work of which she is so much more right than wrong, and the pattern that matters right now goes like this but it remains in tact we almost always see a 127, keep this number in mind, 127.2 fibonacci extension, and rally more on top of that. this is why broaden loves to use the 127.2 extensions as the

initial upside targets when she's setting up a trade that number keeps repeating itself 127.2, this pattern, she sees in action every day on the futures, just about every time frame, down to a five-minute chart where every tick represents a five-minute interval let me give you an example of what we're talking about take a look at the weekly chart of the s&p 500, once this market started rebounding from its lows a year ago, broaden gave a new upside target, told us the s&p was headed for 3102 market, why, it was based on that 127.2 trace of the hideous climb of the bear market sure enough, it took 11 months, but bin go, this november, the s&p finally hit the initial target of broaden's 127.2. when she analyzed other swings on the same chart and put them

to her figonacci prism, it gave a similar target, to 3102. now that we have cleared the first major hurdle, broaden says the s&p 500 has another big picture price target around 3,308. up 3.6%. she thinks these pull backs will be viable, as long as their big picture analysis remains in tact if we're looking for buying opportunities here for stocks, and still represent value, and we know therefore she thinks she's going to give us this. what if we want to make money on individual stock, though we respect index funds, they're our lovy blankets but we like individual stocks in the show. we have to hunt for names that have yet to hit the initial upside targets unlike this whic hit the upside target. how about that call, she waits

out the bear market and zoom i like when someone is right consider the weekly chart of, giving tools to create their own online stories, from late august through early november, shopify's stock got hammered, fell from 409 to 282 as fast growing cloud stocks went out of style on the wall street fashion show it was a brutal correction, but for the past six weeks it has been rebounding like crazy however it has bounced back to 387 as of today. the stock is a long way from making 127.2 retracement of this august decline hasn't been made up yet. 127.2 move in the wake of a correction is the one of the most reliable patterns in the business where does this go, 444, people,

15% from where we're currently trading. if shopify gets hit again, it's worth buying, as long as it doesn't fall blelow the port of 280s she thinks it's going to go to this level, hoping to be able to buy it a little bit lower to get a bigger percentage gain what other high quality stocks haven't recovered from a hideous correction how about cramer fav, nvidia, because of gaming and machine learning, it still hasn't recovered from the melt down, the 4th quarter of last year melt down took the stock from 290 to 120s, and this was because crypto, people using them for crypto and they couldn't tell what the inventory situation was. the stock got clobbered and just now testing ceiling resistance which represents a 61.8% retracement of the 2018 pull back, if the stock can make the

127.2% retracement extension, where does it go, it goes to 338: up 48% from where it's currently trading. that's when broaden thinks nvidia is heading. so do i. she's recommending you wait for a wee bit of a pull back before you pull the trigger for the record, nvidia, my dog had an endoscopy oday, and my 13-year-old rescue is fighting kennel cough as best as he can please, it's apropos nothing, but i had to point it out. we see the same thing in pay pal's weekly chart let's go to that the online payment got rolled this year while stocks started rebounding in october. it's still got a long way to go to reverse that correction, assuming pay pal can hold above its recent lows, mid-90s the floor of support is down 13

bucks from here. broden believes the up trend is in tact. 127.2, where does that go? 128. i'm talking about a 19% gain we might be able to get shopify, nvidia, pay pal, all fantastic companies. finally, broden is intrigued by the weekly chart of something in my travel chest. loves the despot, home depot this is one of the, that's a developer once said i'm thinking about getting a home despot into my mall, i never forgot it that company disappointed investors, it did disappoint they need to upgrade their regular legacy technology systems to bolster sales, and broden is not convinced home depot has put in the bottom yet.

i do think it has. once we have con mfirmation, 217 goes to 247. wow, what needs to happen before she can give home depot her blessing broden is waiting for signals that run from 202 to 209, after a nice bounce today, what kind of buy signal, she likes to ride on one potential signal, when the five-day exponential moving average crosses above the 13-day exponential moving average, blue is five. red is 13. we're there. this is a sign that the stock's short-term has turned positive after a big decline. broden thinks that would mean home depot is done going down. not every one will be a winner broden wants you to define your risk any stock breaks down before the floor support, the up trend has been called into question, her thesis is dead if home dedrops below 202, trade

over bottom line, in a red hot market, there are plenty of stocks to have more room to run. and chart suggests that shopify, and nvidia and pay pal worth owning and home depot might be able to join the list if the stock can show us it's put in a sustainable bottom we should take calls, we should go to laurie in pennsylvania laurie >> hi, jim, this is laurie from the home of the philadelphia eagles first let me wish you a happy holiday and happy and healthy new year to you and your family, and thank you for all you do, and your action alerts club membership, i love it. thank you very much. >> thank you for being a member of the club. we have been having some good ones, back to 3 mill i think today, and we have a really big game sunday, and we have to win. how can i help >> we are going to win this is how you can help anyway, i just found out my mom

went from sac's to t.j.maxx, and i did what you did with your father, looked if the parking lots were fall, employees were happy, customers were happy, it was an incredible experience, so my question to you is with t.j.maxx trading near all time highs, does it still have room to run like miles sanders. >> can i ask laurie a question what i wanted to ask laurie is it's not yjust t.j.maxx, you hav to check out the home goods, what pop and i did, we never went to one store. he would drag me to five, six, seven stores, but i like tjx, and i think it does go higher. at the time, oh, my god, how many stores do we have to visit. darn it, pop, were you ever right. this is a red hot market but there are stocks that have room to run what kind of stocks, shopify,

nvidia, not a dog, the stock and pay pal. and home depot if it puts in the bottom, you know, the cross over there. there's a bunch more "mad money" and how a blow up in a biotech company can offer larger lessons, this is our lessons learned new segment in the sector don't make a move before hearing my take, and a slew of bad news for boeing, wondering why it's stock isn't lower, i'm telling you why that could be the wrong question tonight's edition of the lightning round, so stick with cramer

do you have concerns about mild memory loss related to aging? prevagen is the number one pharmacist-recommended memory support brand. you can find it in the vitamin aisle in stores everywhere. prevagen. healthier brain. better life.

and when you open a new brokerage account, your cash is automatically invested at a great rate. that's why fidelity leads the industry in value while our competition continues to talk. ♪ talk, talk

a stock i'm not familiar with, i tell you i need to do more homework and promise to circle back later because i don't want to give anyone an uninformed off the cuff answer, you deserve better than that i'm very careful about this, especially when we're dealing with small cap speculative biotech stocks that people love to ask me about. however, sometimes we don't get to these homework items fast enough take wave life sciences, that's an early stage genetic medicine company that connecticut asked me about in early october, i took too long, these things are

so hard to do and i got a lot on my plate yesterday, you know what happened, the stock imploded it plummeted 55% on the news that its lead drug candidate wa a failure and plunged 9% today on the same story. that's how bad this one is what really strikes me about the story is just how difficult it would have been for regular investors to see this melt down coming i know that because i was doing research i was doing the research on this one. i know i didn't see it coming, in fact, i was going to come out positive on this show about this wave life sciences because i liked what i saw and isn't that the real lesson here biotech stocks is inherently risky. some of the drug companies will blow up in your face, and you will not see it coming, it's the nature of the beast. i'm a big believer in speculation, you know that, i think there's a place for ultrahigh risk stocks in a

balanced portfolio, they keep things interesting and when they work out, they can make you a fortune, when they don't work out, they can lose you a fortune. that's why you should never speculate with money you can't afford to lose i recommend index funds, so you have saved enough to make it that you can't get hit badly when you buy the wrong individual stocks, particularly the speculative ones think about what happened with the wave life sciences a few days ago, the stock seemed too legit to quit, it has a proprietary platform that is supposed to give an edge on gene therapy for rare diseases. they were working on a therapy for muscular dystrophy, and working on another one nor huntington's disease the drug that blew up yesterday, looked like the real deal in september. waves duchenne muscular

dystrophy had gotten fast tracked from the fda, in phase three clinical trials. everything looked good until it imploded fast tracked by the fda, i got to come out and be positive about this one could you have seen it coming. in retrospect there were some signs there were things wrong. it was widely considered to be disappointing. while the bulls argue the safety data was solid, the numbers we saw said very little about the treatment's actual efficacy, and analysts downgraded way, cutting his price target literally in half, based on concerns about the lead drug and the technology platform then in august, main competitor, suffered a major setback and a month later they got a fast track designation from the fda in short, while there was one warning sign, you had very

little reason to believe this new drug would be a total bust the fda fast track the drug, are they really going to track something fast that doesn't work >> apparently, well, yes the wave announced they are discontinuing to of duchenne muscular dystrophy drugs based on very disappointing, efficacy data this is a disease where you body can't produce an important protein, dystropin, the results showed no change from baseline, despite promising preclinical data, the drug failed. now, the company still has other drugs in the works, including a treatment for huntington's disease. thf this was a major blow, a blow almost nobody saw coming when the fda fast tracks a drug,

it's usually a sign they see something promising but even the fda drops the ball sometimes we're not the only ones who got taken in on this one, though since august, every single analyst covering wave either rated it a buyer hold, going into this news, you had six buys and two holds. people believed. so what do we do now if we own this wave life, people tweeting me, what do you do, what do you do, i don't think it's completely lost. it's not toast the huntington drug could be a very big drug, assuming the data goes away. it might be good got to tell you, after what happened with the duchenne muscular disfi dr muscular dystrophy, i'm not overflowing with confidence in the technology until they show that the platform works i'm not going to recommend it even as it's come down a great deal.

here's the bottom line, when you speculate on early stage biotech stocks, there's always a risk that a promising drug candidate will blow up in your face and your stock will get where he could a-- wrecked that's what happened to wave if you're going to bet on these companies, you need to be aware of the risks and accept the devastating losses they can produce which is what they did in the case of wave life sciences

light round is sponsored by td ameritrade. >> it is time. it is time for the lightning round. and then the lightning round is over, are you ready? that was jeff in california, jeff >> mr. cramer, thank you for taking my call >> you're welcome. >> i'm interested in your opinion of ford. >> get this, many of you have to hold your ears, i don't want you to own ford, i want you to own

the stock of tesla i actually think, i'm not saying one after the other, i'm say both have balance sheets, one has more upside. i want to go to dylan in arkansas dylan. >> hey, jim, thank you for everything that you do i'm a 25-year-old investor, and thinking about adding facebook to my long-term portfolio. >> i am going to approve of that i do think that facebook should get a little bit more involved with the people who use it, so you have some passers, how about mick in wisconsin. >> hi, jim, this is my first time calling i just want to say i love your program. >> thank you >> i'm interested in raytheon. >> i like raytheon, it's a winner >> ted, speak to me. >> mr. cramer. >> yeah. >> hey, i was wondering if the best way to play oil is midstream, what do you think of shell midstream.

>> i like shell midstream partners, i will brace that because it is run by a good company. i need to not go to anybody, and that, ladies and gentlemen is the conclusion of the lightning round. >> the lightning round is sponsored by td ameritrade ♪ ♪ apple card. is a new kind of credit card, created by apple, so it's simple and transparent with a new level of privacy and security. it lives here and here- on your iphone, and it will save you 6% on holiday gifts at apple;

like iphone, apple watch, airpods pro and so much more. ♪ apply in as little as a minute, right in the wallet app.

this market has had an incredible run

so many people missed out on it because they were too busy worrying about why stocks deserve to be lowering, instead of wondering what might send them higher. they're too afraid of the downside to appreciate the existence of the upside. as the risk reward for so many stocks improved dramatically over the whole course of the year, take the biggest negative story, boeing is halting production of the 737 max, even though the stock got hammered yesterday, did you know it's still up for the year? it was flat today. that's astonishing here you have the worst case, the worst case scenario for boeing, yet the stock is holding up surprisingly well, and believe me as someone who follows boeing closely, this was the thing that they were most fearful of so shouldn't the stock be lower? that's the question that defines this market, doesn't it. but the answer is surprisingly straightforward, no. boeing stock should not be that

much lower i mean, maybe to 300, but that's about it see there are too many portfolio managers who want to own the stock because they believe the company will ultimately fix the 737 max, i do too. at the end of the day, the commercial aircraft business, there's boeing and there's air bus, and that's it but the demand for mu planes is tremendous, ten years out, that's why these managers aren't worried about boeing seeking the 250 if everything keeps going wrong, they're much more worried the stock will surge to 400 and they will be left behind because they don't own it. that's the real fear, 400, not 250. same thing ge, we have fabulous analysts that predicted ge's downfall, and these bears, they're still elentless, sayin that there are black holes and hidden issues and generally saying there's way too much wishful thinking why is the stock at eleven and now back down to six because most money managers don't want to miss the come back

of a great american industrial in the time of an economic expansion. they don't want to sit there and say i see ge going up but i have to wait for steve, the analyst jp morgan who hates it, top credit, and at any other time, keep putting the hate on stocks like ge. but this environment is so bullish, that you got to suspend your skepticism except the magic of ge and 11 yes, 2019, is the year that we embrace john, the year of magical stock thinking the market's littered with these stocks, the ones we should have asked, how can it go higher, not why is it lower. for constantly tell you to stick with apple, to own it not trade it, you wouldn't believe the hate mail that i get from professional money managers who are furious i don't see the downside, how the ecosystem would make it more valuable, they don't think about the idea

that there is a long-term value that you could ascribe to each person who buys, that's right. a lifetime how could ceo tim cook juggle both our government, president trump, and their government, president xi, who can do that. you're too focused on what might go wrong isn't it a marvel that he got that right over and over, we have seen stocks go down, refuse to stay down, the announcement of january of this year what a fabulous buying opportunity, same for caterpillar after a terrible quarter, the most miserable results of the year, another great buying time. one last example, think about when nvidia did bottom it didn't happen when things got better it happened when things seemed horrendous and were getting worse. in each case you had to wonder why is this beaten down stock going higher, to do some buying, and felt crazy at the time

i don't have no crystal ball for 2020, i have an attitude you have to weigh the potential upside more heavily than the downside trying to weigh them equally hasn't worked. and let me give you a news flash, i bet it won't work in 2020 either. stick with cramer. term limits. you and i both know we need term limits, that congress shouldn't be a lifetime appointment. but members of congress, and the corporations who've bought our democracy hate term limits. too bad. i'm tom steyer and i approve this message because the only way we get universal healthcare, address climate change and make our economy more fair is to change business as usual in washington.

i'm sure some of you are saying, why didn't i talk more about the impeachment, and we have a vote tomorrow, and that is because i believe that the republicans will not convict and it will be a lot like clinton, which turned out to be a buying opportunity so i don't want to scare anybody out of the market. i do feel that fedex, by the way, is intidicative of problems at fedex, and no other way to read it. and have not been a winner in ecommerce. there are other losers too, and fedex is one of them there's always a bull market somewhere, and i am jim cramer and i will see you tomorrow. ♪ look, a new day

♪ has begun >> welcome to the shark tank, where entrepreneurs seeking an investment will face these sharks. if they hear a great idea, they'll invest their own money or fight each other for a deal. this is "shark tank." ♪ designed to help businesses attract customers. hi, sharks. i'm scott adams. hi, sharks. i'm josh faherty. and we're from sacramento, california. we are the inventors of velocity signs. we are seeking $225,000 in exchange for 15% equity stake in our business.